CL:0000148

Name:	melanocyte
Namespace:	cell;;efo
Definition:	"A pigment cell derived from the neural crest. Contains melanin-filled pigment granules, which gives a brown to black appearance." [SANBI:mhl]
Xrefs:	Expandlinks: BTO:0000847 FMA:70545
Synonyms:	"melanophore" NARROW []
Alt_id:	CL:0000572

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0000147(pigment cell),CL:0000710(neurecto-epithelial cell),EFO:0000700()

Children

is a:	CL:0002566 (dark melanocyte),CL:0002567 (light melanocyte)
derives from:	FF:0000334 (melanocytic induction sample),FF:0000730 (human melanocyte (MC) sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 11274-116H5 (Melanocyte - light, donor1)
• 11351-117H1 (Melanocyte - light, donor2)
• 11423-118G1 (Melanocyte - light, donor3)
• 11502-119F8 (Melanocyte - dark, donor1)
• 11581-120F6
• 11582-120F7 (Melanocyte - dark, donor2)
• 11663-122F7 (Melanocyte - dark, donor3)
• 12627-134E8 (H9 Embryoid body cells, melanocytic induction)
• 12628-134E9 (H9 Embryoid body cells, melanocytic induction)
• 12629-134F1 (H9 Embryoid body cells, melanocytic induction)

... further results Mouse (Mus musculus)

• 11274-116H5 (Melanocyte - light, donor1)
• 11351-117H1 (Melanocyte - light, donor2)
• 11423-118G1 (Melanocyte - light, donor3)
• 11502-119F8 (Melanocyte - dark, donor1)
• 11581-120F6
• 11582-120F7 (Melanocyte - dark, donor2)
• 11663-122F7 (Melanocyte - dark, donor3)
• 12627-134E8 (H9 Embryoid body cells, melanocytic induction)
• 12628-134E9 (H9 Embryoid body cells, melanocytic induction)
• 12629-134F1 (H9 Embryoid body cells, melanocytic induction)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000148 (melanocyte), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
3.89e-139	FFCP PHASE2:Hg19::chrX:9707625..9707629,-	p6@GPR143
3.89e-139	FFCP PHASE1:Hg19::chrX:9707625..9707629,-	p6@GPR143
5.38e-137	FFCP PHASE2:Hg19::chr9:12695585..12695593,+	p24@TYRP1
5.38e-137	FFCP PHASE1:Hg19::chr9:12693291..12693298,+	p33@TYRP1
5.38e-137	FFCP PHASE2:Hg19::chr6:4610902..4610913,+	p1@ENST00000380106
5.38e-137	FFCP PHASE2:Hg19::chr9:12709332..12709345,+	p@chr9:12709332..12709345, +
5.38e-137	FFCP PHASE1:Hg19::chr1:154401791..154401807,+	p11@IL6R
5.38e-137	FFCP PHASE2:Hg19::chr9:12708060..12708071,-	p@chr9:12708060..12708071, -
5.38e-137	FFCP PHASE1:Hg19::chr19:3557867..3557877,-	p7@MFSD12
5.38e-137	FFCP PHASE2:Hg19::chr1:1497497..1497523,-	p1@AK129493
5.38e-137	FFCP PHASE2:Hg19::chr9:12702367..12702377,+	p@chr9:12702367..12702377, +
5.38e-137	FFCP PHASE1:Hg19::chr9:12708978..12708990,+	p@chr9:12708978..12708990, +
5.38e-137	FFCP PHASE2:Hg19::chr16:89986251..89986268,+	p@chr16:89986251..89986268, +
5.38e-137	FFCP PHASE2:Hg19::chr1:154401791..154401807,+	p11@IL6R
5.38e-137	FFCP PHASE2:Hg19::chr9:12693291..12693298,+	p33@TYRP1
5.38e-137	FFCP PHASE1:Hg19::chr9:12695585..12695593,+	p24@TYRP1
5.38e-137	FFCP PHASE2:Hg19::chr19:3557867..3557877,-	p7@MFSD12
5.38e-137	FFCP PHASE1:Hg19::chr6:4610902..4610913,+	p1@ENST00000380106
5.38e-137	FFCP PHASE1:Hg19::chr9:12709332..12709345,+	p@chr9:12709332..12709345, +
5.38e-137	FFCP PHASE1:Hg19::chr9:12708060..12708071,-	p@chr9:12708060..12708071, -
5.38e-137	FFCP PHASE1:Hg19::chr1:1497497..1497523,-	p1@AK129493
5.38e-137	FFCP PHASE1:Hg19::chr9:12702367..12702377,+	p@chr9:12702367..12702377, +
5.38e-137	FFCP PHASE2:Hg19::chr9:12708978..12708990,+	p@chr9:12708978..12708990, +
5.38e-137	FFCP PHASE1:Hg19::chr16:89986251..89986268,+	p@chr16:89986251..89986268, +
3.56e-120	FFCP PHASE1:Hg19::chr1:1497528..1497559,-	p2@AK129493
3.56e-120	FFCP PHASE1:Hg19::chr19:3557918..3557927,-	p8@MFSD12
3.56e-120	FFCP PHASE2:Hg19::chr1:1497528..1497559,-	p2@AK129493
3.56e-120	FFCP PHASE2:Hg19::chr19:3557918..3557927,-	p8@MFSD12
4.24e-120	FFCP PHASE2:Hg19::chr9:12708011..12708027,+	p27@TYRP1
4.24e-120	FFCP PHASE2:Hg19::chr9:12701182..12701196,+	p19@TYRP1
4.24e-120	FFCP PHASE1:Hg19::chr5:159894810..159894819,+	p12@uc003lyl.3
4.24e-120	FFCP PHASE2:Hg19::chr9:12693559..12693562,+	p22@TYRP1
4.24e-120	FFCP PHASE1:Hg19::chr9:12704349..12704362,+	p@chr9:12704349..12704362, +
4.24e-120	FFCP PHASE1:Hg19::chr9:12708011..12708027,+	p27@TYRP1
4.24e-120	FFCP PHASE2:Hg19::chr5:159894810..159894819,+	p12@uc003lyl.3
4.24e-120	FFCP PHASE1:Hg19::chr9:12701182..12701196,+	p19@TYRP1
4.24e-120	FFCP PHASE1:Hg19::chr9:12693559..12693562,+	p22@TYRP1
4.24e-120	FFCP PHASE2:Hg19::chr9:12704349..12704362,+	p@chr9:12704349..12704362, +
5.06e-120	FFCP PHASE1:Hg19::chr9:12704539..12704547,+	p@chr9:12704539..12704547, +
5.06e-120	FFCP PHASE2:Hg19::chr9:12704539..12704547,+	p@chr9:12704539..12704547, +
5.06e-120	FFCP PHASE1:Hg19::chr15:28344426..28344431,-	p2@OCA2
5.06e-120	FFCP PHASE2:Hg19::chr15:28344426..28344431,-	p2@OCA2
6.04e-120	FFCP PHASE2:Hg19::chr9:12695674..12695681,+	p36@TYRP1
6.04e-120	FFCP PHASE1:Hg19::chr9:12695674..12695681,+	p36@TYRP1
7.21e-120	FFCP PHASE2:Hg19::chr12:56351078..56351092,-	p@chr12:56351078..56351092, -
7.21e-120	FFCP PHASE1:Hg19::chr12:56351078..56351092,-	p@chr12:56351078..56351092, -
1.29e-117	FFCP PHASE2:Hg19::chr17:77923816..77923828,-	p@chr17:77923816..77923828, -
1.29e-117	FFCP PHASE2:Hg19::chr9:12709200..12709209,+	p@chr9:12709200..12709209, +
1.29e-117	FFCP PHASE2:Hg19::chr3:69951861..69951868,+	p@chr3:69951861..69951868, +
1.29e-117	FFCP PHASE2:Hg19::chr1:1497446..1497455,-	p4@AK129493
1.29e-117	FFCP PHASE1:Hg19::chr15:28360793..28360804,-	p@chr15:28360793..28360804, -
1.29e-117	FFCP PHASE2:Hg19::chr19:3557800..3557811,-	p9@MFSD12
1.29e-117	FFCP PHASE2:Hg19::chr11:48066945..48066951,+	p@chr11:48066945..48066951, +
1.29e-117	FFCP PHASE2:Hg19::chr11:2920857..2920864,+	p13@SLC22A18
1.29e-117	FFCP PHASE2:Hg19::chr2:128400821..128400830,-	p39@LIMS2
1.29e-117	FFCP PHASE2:Hg19::chr15:28360793..28360804,-	p@chr15:28360793..28360804, -
1.29e-117	FFCP PHASE1:Hg19::chr1:1497566..1497576,-	p3@AK129493
1.29e-117	FFCP PHASE2:Hg19::chr9:12709019..12709029,+	p@chr9:12709019..12709029, +
1.29e-117	FFCP PHASE1:Hg19::chr17:77925869..77925876,-	p@chr17:77925869..77925876, -
1.29e-117	FFCP PHASE1:Hg19::chr15:42694665..42694671,+	p16@CAPN3
1.29e-117	FFCP PHASE1:Hg19::chr15:28360857..28360860,-	p@chr15:28360857..28360860, -
1.29e-117	FFCP PHASE1:Hg19::chr1:212594718..212594723,+	p@chr1:212594718..212594723, +
1.29e-117	FFCP PHASE1:Hg19::chr9:12704666..12704671,+	p@chr9:12704666..12704671, +
1.29e-117	FFCP PHASE1:Hg19::chr22:20878094..20878105,+	p41@MED15
1.29e-117	FFCP PHASE1:Hg19::chr9:12701691..12701717,+	p34@TYRP1
1.29e-117	FFCP PHASE2:Hg19::chr15:42694665..42694671,+	p16@CAPN3
1.29e-117	FFCP PHASE1:Hg19::chr6:4610888..4610895,+	p2@ENST00000380106
1.29e-117	FFCP PHASE2:Hg19::chr15:28360857..28360860,-	p@chr15:28360857..28360860, -
1.29e-117	FFCP PHASE1:Hg19::chr17:77923816..77923828,-	p@chr17:77923816..77923828, -
1.29e-117	FFCP PHASE1:Hg19::chr9:12709200..12709209,+	p@chr9:12709200..12709209, +
1.29e-117	FFCP PHASE1:Hg19::chr3:69951861..69951868,+	p@chr3:69951861..69951868, +
1.29e-117	FFCP PHASE1:Hg19::chr1:1497446..1497455,-	p4@AK129493
1.29e-117	FFCP PHASE1:Hg19::chr11:48066945..48066951,+	p@chr11:48066945..48066951, +
1.29e-117	FFCP PHASE1:Hg19::chr2:128400821..128400830,-	p39@LIMS2
1.29e-117	FFCP PHASE2:Hg19::chr1:1497566..1497576,-	p3@AK129493
1.29e-117	FFCP PHASE2:Hg19::chr17:77925869..77925876,-	p@chr17:77925869..77925876, -
1.29e-117	FFCP PHASE1:Hg19::chr11:2920857..2920864,+	p13@SLC22A18
1.29e-117	FFCP PHASE2:Hg19::chr1:212594718..212594723,+	p@chr1:212594718..212594723, +
1.29e-117	FFCP PHASE2:Hg19::chr9:12704666..12704671,+	p@chr9:12704666..12704671, +
1.29e-117	FFCP PHASE1:Hg19::chr19:3557800..3557811,-	p9@MFSD12
1.29e-117	FFCP PHASE2:Hg19::chr22:20878094..20878105,+	p41@MED15
1.29e-117	FFCP PHASE2:Hg19::chr9:12701691..12701717,+	p34@TYRP1
1.29e-117	FFCP PHASE2:Hg19::chr6:4610888..4610895,+	p2@ENST00000380106
1.29e-117	FFCP PHASE1:Hg19::chr9:12709019..12709029,+	p@chr9:12709019..12709029, +
4.33e-107	FFCP PHASE1:Hg19::chr22:20878024..20878053,+	p16@MED15
4.33e-107	FFCP PHASE1:Hg19::chr17:77924675..77924686,-	p3@TBC1D16
4.33e-107	FFCP PHASE2:Hg19::chr9:12702314..12702344,+	p@chr9:12702314..12702344, +
4.33e-107	FFCP PHASE2:Hg19::chr9:12698593..12698608,+	p20@TYRP1
4.33e-107	FFCP PHASE1:Hg19::chr9:12702379..12702409,+	p@chr9:12702379..12702409, +
4.33e-107	FFCP PHASE2:Hg19::chr9:12694022..12694033,+	p15@TYRP1
4.33e-107	FFCP PHASE2:Hg19::chr9:5892516..5892527,+	p3@MLANA
4.33e-107	FFCP PHASE2:Hg19::chr22:20878024..20878053,+	p16@MED15
4.33e-107	FFCP PHASE2:Hg19::chr17:77924675..77924686,-	p3@TBC1D16
4.33e-107	FFCP PHASE2:Hg19::chr9:12702379..12702409,+	p@chr9:12702379..12702409, +
4.33e-107	FFCP PHASE1:Hg19::chr9:12694022..12694033,+	p15@TYRP1
4.33e-107	FFCP PHASE1:Hg19::chr9:12702314..12702344,+	p@chr9:12702314..12702344, +
4.33e-107	FFCP PHASE1:Hg19::chr9:12698593..12698608,+	p20@TYRP1
4.33e-107	FFCP PHASE1:Hg19::chr9:5892516..5892527,+	p3@MLANA
5.07e-107	FFCP PHASE1:Hg19::chr9:5897549..5897564,+	p4@MLANA
5.07e-107	FFCP PHASE1:Hg19::chr9:12693305..12693317,+	p10@TYRP1

Showing 1 to 100 of 100 entries